Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0DJ6G
|
||||
Former ID |
DNC008454
|
||||
Drug Name |
4-butyl-N-(7-hydroxynaphthalen-1-yl)benzamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [529389] | ||
Structure |
Download2D MOL |
||||
Formula |
C21H21NO2
|
||||
Canonical SMILES |
CCCCC1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C=C(C=C3)O
|
||||
InChI |
1S/C21H21NO2/c1-2-3-5-15-8-10-17(11-9-15)21(24)22-20-7-4-6-16-12-13-18(23)14-19(16)20/h4,6-14,23H,2-3,5H2,1H3,(H,22,24)
|
||||
InChIKey |
KSWNGABTIMONPN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Inhibitor | [529389] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.